COGT — Cogent Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Cogent Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	242	220	259	266	287
Net Total Accounts Receivable
Net Total Receivables	0	—	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	245	223	265	271	296
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.75	4.48	31.1	30.3	26.6
Long Term Investments
Other Long Term Assets
Total Assets	251	232	301	313	328
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	13.1	17.1	26.8	38.2	55.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	16.2	17.9	45.1	55.6	71.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	235	214	256	258	256
Total Liabilities & Shareholders' Equity	251	232	301	313	328
Total Common Shares Outstanding
Total Preferred Shares Outstanding